Jacques Blacher
Overview
Explore the profile of Jacques Blacher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
274
Citations
4330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheddani L, Lelong H, Goldberg M, Zins M, Blacher J, Kab S
J Hypertens
. 2025 Feb;
PMID: 40008529
Introduction: Estimating hypertension incidence and improving screening in general population could enhance blood pressure control and decrease cardiometabolic risks. Identifying those likely to develop hypertension is essential. Our study focused...
2.
Athanasopoulou E, Karachalias F, Yofoglu L, Kanatas P, Danninger K, Weber T, et al.
Hypertens Res
. 2024 Dec;
48(3):1099-1108.
PMID: 39715791
The prevalence of systolic hypertension phenotypes based on simultaneous 24-h brachial (br) and aortic (ao) ambulatory blood pressure monitoring (ABPM) remains unknown. We sought to describe their prevalence and associations...
3.
Olie V, Blacher J
Arch Cardiovasc Dis
. 2024 Dec;
117(12):658-659.
PMID: 39681406
No abstract available.
4.
Olie V, Grave C, Helft G, Nguyen-Thanh V, Andler R, Quatremere G, et al.
Arch Cardiovasc Dis
. 2024 Dec;
117(12):770-784.
PMID: 39665875
Cardiovascular diseases (CVDs) have a multifactorial origin. Among the risk factors, so-called behavioural risk factors play a major role in the onset of these diseases: smoking, unhealthy diet, lack of...
5.
Grave C, Bonaldi C, Carcaillon-Bentata L, Gabet A, Halimi J, Tzourio C, et al.
Hypertension
. 2024 Dec;
82(2):357-369.
PMID: 39648886
Background: Hypertension is the most common chronic disease and a major modifiable risk factor for cardio-cerebrovascular and renal diseases. This study estimated the national burden of hypertension, defined as systolic...
6.
Gabet A, Grave C, Aboyans V, Lailler G, Tuppin P, Kownator S, et al.
Arch Cardiovasc Dis
. 2024 Dec;
117(12):738-750.
PMID: 39638732
Background: Peripheral arterial diseases (PADs) account for much of the morbidity and hospitalizations experienced by patients with cardiovascular disease. Epidemiological data on these diseases are lacking in France. Aims: To...
7.
Grave C, Gabet A, Tribouilloy C, Cohen A, Lailler G, Weill A, et al.
Arch Cardiovasc Dis
. 2024 Dec;
117(12):669-681.
PMID: 39632129
Background: Demographic changes and improvements in the diagnosis and treatment of valvular heart diseases (VHDs) have led to changes in its epidemiological profile. Aims: To describe the epidemiology of VHD...
8.
Gabet A, Blacher J, Tuppin P, Lailler G, Grave C, Sanchez O, et al.
Arch Cardiovasc Dis
. 2024 Dec;
117(12):715-724.
PMID: 39632128
Background: Few epidemiological data are available for venous thromboembolism (VTE) at French national and subnational levels. Aims: To quantify VTE events in France in 2022 and describe the features of...
9.
Gabet A, Grave C, Bonaldi C, Blacher J, Olie V
Arch Cardiovasc Dis
. 2024 Dec;
117(12):660-668.
PMID: 39632127
Background: Elevated concentrations of low-density lipoprotein cholesterol (LDL-C) are highly prevalent and are associated with the development of cardiovascular diseases. Aim: To estimate the proportion of cardiovascular disease cases attributable...
10.
Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012-2022
Olie V, Isnard R, Pousset F, Grave C, Blacher J, Gabet A
ESC Heart Fail
. 2024 Nov;
PMID: 39601328
Aims: We aim to describe the incidence of HF hospitalization in France in the post-pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on...